Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Burn Injuries

Burn Injuries

Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same authorSame journal

Radiographic Versus Pathology-Integrated Response for Assessing Optimal Surgical Timing After Neoadjuvant Imatinib in Patients With Locally Advanced KIT Exon 11-Mutant GIST.

Annals of surgery·2026

Same author

Prehabililtation in Retroperitoneal Sarcomas.

Journal of surgical oncology·2026

Same author

Global Consensus on the Management of Primary Localized Chordoma.

JAMA oncology·2026

Same author

Radiologic response assessment in patients with desmoid-type fibromatosis treated with percutaneous cryoablation.

European radiology experimental·2026

Same author

Any impact of pre-operative radiotherapy on renal function in retroperitoneal soft tissue sarcomas? A secondary ancillary analysis of the EORTC 62092 STRASS 1 trial.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

Same author

Corrigendum to "Management of atypical cartilaginous tumors (ACT): An Italian Sarcoma Group (ISG) consensus document" [Crit. Rev. Oncol. Hematol. 223 (2026) 105358].

Critical reviews in oncology/hematology·2026

Search research articles

Related Experiment Video

Updated: Jul 3, 2026

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

Global Variations in Patterns of Care for Retroperitoneal Sarcoma.

Hayden Snow¹, Marco Fiore², Jing Xie¹

¹Division of Cancer Surgery, Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.

Annals of Surgery

|June 16, 2025

Summary

Patterns of care for retroperitoneal sarcoma (RPS) vary significantly worldwide, particularly in surgical strategies like comprehensive resection (CR) for liposarcoma and the use of chemotherapy for leiomyosarcoma. Radiotherapy use decreased after the STRASS trial.

Keywords:

Retroperitoneal sarcoma Sarcoma

More Related Videos

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Related Experiment Videos

Last Updated: Jul 3, 2026

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Area of Science:

Oncology
Surgical Oncology
Sarcoma Research

Background:

Retroperitoneal sarcoma (RPS) treatment presents challenges due to its rarity and complexity.
Global variations in diagnostic and therapeutic approaches for RPS are not well-characterized.

Purpose of the Study:

To investigate international variations in the management of primary retroperitoneal sarcoma (RPS).
To analyze differences in diagnostic work-up, surgical strategies (including comprehensive resection), and neoadjuvant/adjuvant therapies across global sarcoma centers.

Main Methods:

Retrospective analysis of 1718 primary RPS cases from 19 international referral centers.
Data collected prospectively from Feb 2017 - July 2022 within the RESAR repository (NCT03838718).
Centers categorized as high-volume (HVC) or low-volume (LVC); comprehensive resection (CR) defined as en-bloc resection of ipsilateral kidney and colon.

Main Results:

Preoperative biopsy was common (98%) for non-liposarcoma RPS.
Significant variation in CR for liposarcoma (IQR 37%), especially in LVC (IQR 39.5%) vs. HVC (IQR 9.5%).
Chemotherapy use was low for liposarcoma (0%) but varied for leiomyosarcoma (10%, IQR 26%); radiotherapy use was low overall but higher in HVC (18.5%) vs. LVC (5%), decreasing post-STRASS trial.

Conclusions:

Agreement exists on biopsy for non-liposarcomas, chemotherapy for liposarcoma, and radiotherapy for leiomyosarcoma.
Equipoise suggested for chemotherapy in leiomyosarcoma and the value of CR in liposarcoma.
Reduced radiotherapy use post-STRASS trial indicates acceptance of its findings.